Sign In
Buy OGI
$0.96
-0.0047 (-0.487%)
At Close: Jun 22, 2026
TORONTO--(BUSINESS WIRE)--Organigram Global Inc. (NASDAQ: OGI) (TSX: OGI), (the “Company” or “Organigram Global”), the cannabis leader in Canada by market share, is pleased to announce its ina
Organigram Enters U.S. Through Acquisition of Collective Project Beverages
07:47am, Tuesday, 01'st Apr 2025
TORONTO--(BUSINESS WIRE)--Organigram Global Inc. (NASDAQ: OGI) (TSX: OGI), (the "Company" or "Organigram"), Canada's #1 cannabis company by market share, is pleased to announce the acquisition of 100%
Organigram Unveils Bold New Brand Identity Reflecting Market Leadership Position in Canada and Growing International Presence
06:00am, Wednesday, 26'th Mar 2025
TORONTO--(BUSINESS WIRE)--Organigram Holdings Inc. (NASDAQ: OGI) (TSX: OGI), (the “Company” or “Organigram”), a leading licensed producer of cannabis, is proud to announce its official rebrand
TORONTO--(BUSINESS WIRE)--Organigram Holdings Inc. (“Organigram” or the “Company”) (TSX: OGI) (NASDAQ: OGI) announced today the results of voting at its annual general and special meeting of s
Organigram Closes Third Tranche of Previously Announced BAT Private Placement Investment
06:00am, Monday, 03'rd Mar 2025
TORONTO--(BUSINESS WIRE)--Organigram Holdings Inc. (NASDAQ: OGI) (TSX: OGI), (the “Company” or “Organigram”), a leading licensed producer of cannabis, announced today that on February 28, 2025
Organigram Reports In-Line Q1 Results As Cannabis Sector Tanks
09:38pm, Sunday, 23'rd Feb 2025
Organigram reported improved financial results for Q1-2025. OGI expects revenue to increase for Q2 as well as cash positions. OGI:CA sees growth in its international cannabis sales and Canadian sales.
Organigram Is A Small-Cap Bargain
07:52am, Sunday, 23'rd Feb 2025
Organigram's stock has declined significantly, but my bullish outlook remains due to strong fundamentals, strategic investments, and potential acquisition by British American Tobacco. The company repo
On Tuesday, Cannabis producer Organigram Holdings Inc OGI reported first-quarter 2025 gross sales of CA$66.8 million, up 19% year-over-year, beating the consensus of CA$65.4 million.
Organigram Holdings Inc. (OGI) Q1 2025 Earnings Call Transcript
09:45am, Tuesday, 11'th Feb 2025
Organigram Holdings Inc. (NASDAQ:OGI ) Q1 2025 Earnings Conference Call February 11, 2025 8:00 AM ET Company Participants Max Schwartz - Director of IR Beena Goldenberg - CEO Greg Guyatt - CFO Confere
OrganiGram (OGI) Reports Q1 Loss, Lags Revenue Estimates
09:36am, Tuesday, 11'th Feb 2025
OrganiGram (OGI) came out with a quarterly loss of $0.05 per share versus the Zacks Consensus Estimate of a loss of $0.03. This compares to loss of $0.14 per share a year ago.
Organigram Reports First Quarter Fiscal 2025 Results
06:00am, Tuesday, 11'th Feb 2025
TORONTO--(BUSINESS WIRE)--Organigram Holdings Inc. (NASDAQ: OGI) (TSX: OGI), (the “Company” or “Organigram”), a leading licensed producer of cannabis, announced its results for the first quart
Organigram to Report First Quarter Fiscal 2025 Results on February 11, 2025
06:00pm, Tuesday, 04'th Feb 2025
TORONTO--(BUSINESS WIRE)--Organigram Holdings Inc. (NASDAQ: OGI) (TSX: OGI), the parent company of Organigram Inc. (together, the “Company” or “Organigram”), a leading licensed producer of can
Organigram: Long Term Growth Improving With International And Domestic Cannabis Expansion (Rating Upgrade)
09:00am, Sunday, 22'nd Dec 2024
Organigram reported Q4-2024 financial results earlier this week and show improved revenues, profit margins, net loss, and increased cash. The company announced the acquisition of Canadian private cann
Organigram Holdings Inc. (OGI) Q4 2024 Earnings Call Transcript
12:54pm, Wednesday, 18'th Dec 2024
Organigram Holdings Inc. (NASDAQ:OGI ) Q3 2024 Earnings Conference Call December 18, 2024 8:00 AM ET Company Participants Max Schwartz - Director of IR Beena Goldenberg - CEO Tim Emberg - CCO Greg Guy
Canada's Organigram shops for U.S. pot businesses with backing from British American Tobacco
08:43am, Wednesday, 18'th Dec 2024
Legal cannabis company grows revenue and narrows its loss as it continues its acquisition push.
